Newsletter | July 23, 2025

07.23.25 -- Bioprocess Excellence: Strategies For Speed, Cost, And Quality

Streamlining Drug Development From Developability Assessment To High-Concentration Formulation Development

Explore a strategic approach to accelerating biologics formulation by gaining early insight into molecular properties and optimizing high-concentration conditions with minimal protein input, making faster, data-driven decisions that reduce risk and streamline drug development.

 

Optimizing DSP Development: Faster Timelines, Lower Costs, And High-Quality Processes

A key first step in technology transfer is conducting a detailed facility fit assessment and gap analysis that evaluates the receiving site's manufacturing capabilities, process controls, analytical needs, material compatibility, and facility design.

 

Redefining Bispecific Antibody Development With Structural Innovation And Enhanced Manufacturability

Follow along as Derrick Katayama, Lead Scientist of Formulation Development at Samsung Biologics explores the key challenges faced during biopharmaceutical studies and highlights the latest techniques and innovative solutions that can help overcome these obstacles.

 

SOLUTIONS

 

Samsung Biologics - We Predict, Commit, And Deliver On Time As Promised

Samsung Biologics is a fully integrated, end-to-end CDMO partner offering seamless development and manufacturing services from cell line development to final aseptic fill/finish for biologics. Keeping the highest standards of commercialization in mind, we expand our development portfolio and continue to offer the most optimized service to fit client’s needs. Our facilities are cGMP compliant with bioreactor sizes ranging from small to large scale, enabling us to better serve the various needs of our clients and to meet growing biomanufacturing demands.

 

•  Download Samsung Biologics Organoid Brochure

•  Download Samsung Biologics CMO Brochure

•  Download Samsung Biologics ADC Brochure

 

Request Information